Company Data
Longeveron Inc.
Ticker
LGVN
Current Price
$1.92 -4.48%
Market Cap
$4.8M
Price Target
Refer to Report
Volume
459.0K
52wk Range
$1.62 - $44
Overview
Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer’s disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS).